AMI Cardiogenic Shock

Clinical Evidence

Key Findings from the National Cardiogenic Shock Initiative Study 1,2,3

  • Identify and support cardiogenic shock early
  • Aggressive down titration inotropes
  • Identify inadequate left ventricular (LV) support and escalate, if CPO <0.6
  • Identify right ventricular (RV) dysfunction early and support
  • Systematically use right heart catheter (RHC) to guide therapy

Impella® Clinical Evidence Pathway to Class I Recommendation

Impella clinical evidence has established safety and effectiveness and validated best practices.

The Procedure

Learn more about femoral access explant techniques and other best practices.

References

  1. Tehrani, et al. (2019). JACC, 73, 1659-1669.
  2. Basir, M.B., et al. (2019). Catheter Cardiovasc Interv, 93(7), 1173-1183.
  3. O’Neill, W.W., (2020). TCT Connect 2020

NPS-1187